MedPath
NMPA Approval

Vildagliptin Tablets

国药准字H20243430

April 7, 2024

Drug Information

维格列汀片

片剂

50mg

化学药品

April 7, 2024

Company Information

Applicant Company

浙江省宁波市北仑区大榭街道滨海西路85号

Manufacturing Company

浙江省宁波市北仑区大榭街道滨海西路85号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

维格列汀片 - NMPA 批准文号 | MedPath